Received: 21 June 2022
Accepted: 23 August 2022
First Online: 3 September 2022
: The study was approved by the medical ethical committee of the VU University and was in accordance with the Helsinki Declaration of 1975. All participants gave written informed consent.
: Not applicable.
: Jarith Ebenau reports no disclosures relevant to the manuscript.Denise Visser reports no disclosures relevant to the manuscript.Lior Kroeze reports no disclosures relevant to the manuscript.Mardou van Leeuwenstijn reports no disclosures relevant to the manuscript.Argonde van Harten reports no disclosures relevant to the manuscript.Albert Windhorst reports no disclosures relevant to the manuscript.Sandeep Golla reports no disclosures relevant to the manuscript.Ronald Boellaard reports no disclosures relevant to the manuscript.Philip Scheltens has acquired grant support (for the institution) from Biogen. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Probiodrug Biogen, EIP Pharma, Merck AG.Frederik Barkhof is a consultant for Biogen-Idec, Bayer-Schering, Merck-Serono, Roche, NovartisIXICO and Combinostics; has received sponsoring from European Commission-Horizon 2020, National Institute for Health Research-University College London Hospitals Biomedical Research Centre, TEVA, Novartis, and Biogen; and serves on the editorial boards of <i>Radiology</i>, <i>Brain</i>, <i>Neuroradiology</i>, <i>Multiple Sclerosis Journal</i>, and <i>Neurology</i>.Bart van Berckel has received research support from EU-FP7, CTMM, ZonMw, NWO, and Alzheimer Nederland. BvB has performed contract research for Rodin, IONIS, AVID, Eli Lilly, UCB, DIAN-TUI, and Janssen. BvB was a speaker at a symposium organized by Springer Healthcare. BvB has a consultancy agreement with IXICO for the reading of PET scans. BvB is a trainer for GE. BvB only receives financial compensation from Amsterdam UMC.Wiesje van der Flier Research programs have been funded by ZonMW, NWO, EU-FP7, EU-JPND, Alzheimer Nederland, CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Pasman stichting, Biogen MA Inc., Boehringer Ingelheim, Life-MI, AVID, Roche BV, Fujifilm, Combinostics. WF holds the Pasman chair. WF has performed contract research for Biogen MA Inc and Boehringer Ingelheim. WF has been an invited speaker at Boehringer Ingelheim, Biogen MA Inc., Danone, Eisai and WebMD Neurology (Medscape). WF is consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA Inc. WF was associate editor at <i>Alzheimer’s Research & Therapy</i> (2020-2021); she is associate editor of <i>Brain</i> (2021-). All funding is paid to her institution.